arrow
S

Susana Perez-Gutthann

University of Iceland
H指数:38
被引数:7,268

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts
2024-01-170
OA
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force

统一的协议模板,以增强评估治疗效果的真实世界证据研究的假设的可重复性: ISPE/ISPOR联合工作组的良好实践报告

2022-10-0134
OAAI
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

局部使用他克莫司和吡美莫司的使用者患皮肤癌和淋巴瘤的长期风险: Protopic联合欧洲纵向淋巴瘤和皮肤癌评估 (JOELLE) 队列研究扩展的最终结果

2021-12-0120
OAAI
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Mirabe使用者与抗毒蕈碱治疗使用者治疗膀胱过度活动症的心血管风险比较: 一项非干预性跨国队列研究的结果

2021-07-087
OAAI
Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom

在英国临床实践研究数据链 (CPRD) 的一项非干预性队列研究中,使用阿地溴铵不会增加死亡风险

2019-06-014
OAAI
Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators
2019-04-0149
OAAI
Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources
2019-03-0420
OAAI
Agomelatine and other antidepressants and the risk of acute liver injury (ALI), a post authorisation safety study (PASS) in four European countries
2019-01-010
PREAI
A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)
2018-03-0183
OAAI
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)
2016-10-0459
OAAI